日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Tirzepatide on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the SURMOUNT-OSA randomized trial

替拉帕肽对阻塞性睡眠呼吸暂停相关心血管代谢风险的影响:SURMOUNT-OSA随机试验的次要终点

Malhotra, Atul; Grunstein, Ronald; Azarbarzin, Ali; Sands, Scott; Somers, Virend K; Aronne, Louis J; Jastreboff, Ania M; Lou, Jitong; Chakladar, Sujatro; Dunn, Julia P; Bunck, Mathijs C; Bednarik, Josef

Tirzepatide for sleep-disordered breathing in SURMOUNT-OSA: Time course and association with body weight

替拉帕肽治疗SURMOUNT-OSA睡眠呼吸障碍:时间进程及与体重的关系

Malhotra, Atul; Grunstein, Ronald R; Azarbarzin, Ali; Sands, Scott A; Dang, Xiangnan; Chakladar, Sujatro; Dunn, Julia P; Falcon, Beverly; Bednarik, Josef

Effect of tirzepatide treatment on patient-reported outcomes among SURMOUNT-OSA participants with obstructive sleep apnea and obesity

替泽帕肽治疗对SURMOUNT-OSA研究中患有阻塞性睡眠呼吸暂停和肥胖症的参与者患者报告结局的影响

Kanu, Chisom; Shinde, Shraddha; Chakladar, Sujatro; Dennehy, Ellen B; Weaver, Terri E; Poon, Jiat Ling; Malhotra, Atul

Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity

替泽帕肽治疗阻塞性睡眠呼吸暂停和肥胖症

Malhotra, Atul; Grunstein, Ronald R; Fietze, Ingo; Weaver, Terri E; Redline, Susan; Azarbarzin, Ali; Sands, Scott A; Schwab, Richard J; Dunn, Julia P; Chakladar, Sujatro; Bunck, Mathijs C; Bednarik, Josef

Tirzepatide for the treatment of obstructive sleep apnea: Rationale, design, and sample baseline characteristics of the SURMOUNT -OSA phase 3 trial

替泽帕肽治疗阻塞性睡眠呼吸暂停:SURMOUNT-OSA 3期试验的原理、设计和样本基线特征

Malhotra, Atul; Bednarik, Josef; Chakladar, Sujatro; Dunn, Julia P; Weaver, Terri; Grunstein, Ron; Fietze, Ingo; Redline, Susan; Azarbarzin, Ali; Sands, Scott A; Schwab, Richard J; Bunck, Mathijs C

Studying dimensions of representation: introducing the Belgian RepResent panel (2019–2021)

研究代表性的维度:介绍比利时 RepResent 小组(2019-2021 年)

Chakladar, Sujatro; Rosin, Samuel; Hudgens, Michael G; Halloran, M Elizabeth; Clemens, John D; Ali, Mohammad; Emch, Michael E; Michel, Elie; Feitosa, Fernando; Lefevere, Jonas; Pilet, Jean-Benoît; van Erkel, Patrick; van Haute, Emilie

Effects of Exogenous Ketones on Blood β-OHB and Glucose: A Systematic Review and Meta-Analysis

外源性酮对血液β-羟基丁酸和葡萄糖的影响:系统评价和荟萃分析

Hardy, Shakia T; Loehr, Laura R; Butler, Kenneth R; Chakladar, Sujatro; Chang, Patricia P; Folsom, Aaron R; Heiss, Gerardo; MacLehose, Richard F; Matsushita, Kunihiro; Avery, Christy L; Dave, Aamir S; Moy, Stanley; Lockridge, Connor; Paciullo, Kristen; Trible, Ronald; Falkenhain, Kaja; Daraei, Ali; Forbes, Scott; Little, Jonathan

Baricitinib and primary biliary cholangitis

巴瑞替尼和原发性胆汁性胆管炎

Gordon, Stuart C; Trudeau, Sheri; Regev, Arie; Uhas, Jonathan M; Chakladar, Sujatro; Pinto-Correia, Ana; Gottlieb, Klaus; Schlichting, Doug

Heterogeneity in Blood Pressure Transitions Over the Life Course: Age-Specific Emergence of Racial/Ethnic and Sex Disparities in the United States

生命历程中血压变化的异质性:美国不同年龄段种族/民族和性别差异的出现

Hardy, Shakia T; Holliday, Katelyn M; Chakladar, Sujatro; Engeda, Joseph C; Allen, Norrina B; Heiss, Gerardo; Lloyd-Jones, Donald M; Schreiner, Pamela J; Shay, Christina M; Lin, Danyu; Zeng, Donglin; Avery, Christy L

Targeting physical activity interventions for adults: When should intervention occur?

针对成年人的身体活动干预:何时进行干预?

Holliday, Katelyn M; Lin, Dan Yu; Chakladar, Sujatro; Castañeda, Sheila F; Daviglus, Martha L; Evenson, Kelly R; Marquez, David X; Qi, Qibin; Shay, Christina M; Sotres-Alvarez, Daniela; Vidot, Denise C; Zeng, Donglin; Avery, Christy L